MedTrace Logo

Efficacy Study of Colistimethate Sodium Inhalation in Patients With Ventilator-associated Pneumonia

NCT01975350 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 49

Last updated 2021-03-16

No results posted yet for this study

Summary

There might be additional benefit on clinical outcomes from adjunctive colistimethate sodium inhalation as therapy for multidrug resistant Gram-negative ventilator-associated pneumonia.

Conditions

  • Ventilator Associated Pneumonia

Sponsors & Collaborators

  • National Taiwan University Hospital

    lead OTHER

Principal Investigators

  • Wang-Huei Sheng, M.D. Ph.D · Center of Infection Control of National University Hospital

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-10-01
Primary Completion
2016-02-04
Completion
2017-08-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01975350 on ClinicalTrials.gov